Available from: Yang M, Hu X, Xie L, Zhang L, Zhou J, Lin J, et al
Talk to a real person no AI, no BOTS and no SCRIPTS
Glucagon receptor-mediated effects introduce additional considerations: Potential for transient increases in heart rate (also observed with GLP-1R agonists) Theoretical risk of hyperglycaemia from glucagon signalling, though phase 2 trial data suggest this is counterbalanced by concurrent GLP-1R and GIPR agonism In phase 2 trials, the most commonly reported adverse events were gastrointestinal in nature, consistent with the class
LOMAIRA can help to suppress appetite, eat less, and lose weight
Interface polymerization synthesis of conductive polymer/graphite oxide@sulfur composites for high-rate lithium-sulfur batteries